Click here for pdf version of this press release

InfuSystem Holdings, Inc. the leading provider of ambulatory infusion pump services for administering chemotherapy, today announced the appointment of David M. Haar to the newly created position of Vice President of Marketing.

Prior to joining InfuSystem, Mr. Haar was Vice President of Marketing at National Medical Health Card where he led all marketing and communications initiatives for the national pharmacy benefits manager during a period of rapid growth. Prior to that, he was with MapInfo, a leading provider of location intelligence solutions where he directed marketing programs and demand generation activities as the company' grew from $40MM to $140MM.

"We are impressed with David's track record as well as his vision for our marketing efforts," commented Steve Watkins, chief executive officer, InfuSystem. "His expertise with positioning, branding and lead generation coupled with his business-to-business and consumer marketing experience are perfectly suited to InfuSystem's needs. We look forward to his valuable contributions to our growth."

Mr. Haar commented, "For many cancer patients, continuous infusion therapies decrease the debilitating side effects of chemotherapy, allowing them to maintain a more normal life during their treatment. And, due to the lower toxicity, many patients are able to complete their treatments without disruption, leading to improved therapeutic outcomes and increased overall survival. It's a powerful story and I look forward to getting this message out into the marketplace."

About InfuSystem Holdings, Inc.

InfuSystem provides external ambulatory infusion pump services to doctors and their patients allowing for the gradual delivery of a drug over a period of days in the privacy of one's home, rather than higher dose treatments, as is the case of chemotherapy administered in a hospital setting or doctor's office.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks detailed from time to time in InfuSystem’s publicly filed documents.

###